期刊文献+

肝细胞癌的分子靶向治疗进展 被引量:4

Advances in molecularly targeted therapy of hepatocellular carcinoma
下载PDF
导出
摘要 肝细胞癌是临床常见的恶性肿瘤,传统的手术及化疗难以使患者受益。近年来,分子靶向治疗对一些肿瘤已取得突破性进展,肝癌的分子靶向治疗也在临床试验中取得了令人鼓舞的结果。本文针对肝癌的分子靶向治疗的研究进展做一综述。 Hepatocellular carcinoma is a common malignant tumor,traditional surgery and chemotherapy provide unremarkable benefit.The molecularly targeted therapy in some cancers has made dramatic progress in recent years,and inspring results have also achieved in clinical trials.This review attempts to concisely summarize the molecularly targeted therapy of advanced hepatocellular carcinoma.
作者 陈磊 李德卫
出处 《胃肠病学和肝病学杂志》 CAS 2010年第8期694-697,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 肝细胞癌 分子靶向治疗 Hepatocellular carcinoma Molecularly targeted therapy
  • 相关文献

参考文献3

二级参考文献41

  • 1Zhi-Zhen Dong,Deng-Fu Yao,Deng-Bing Yao,Xin-Hua Wu,Wei Wu,Li-Wei Qiu,Dao-Rong Jiang,Jian-Hua Zhu,Xian-Yong Meng.Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(30):4655-4660. 被引量:45
  • 2Okada T, Sawada T, Kubota K. Rapamycin enhances the anti-tumor effect of gemcitabine in pancreatic cancer cells. Hepatogastroenterology,2007,54 : 2129-2133.
  • 3Huynh H, Teo CC, Soo KC. Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer. Mol Cancer Ther,2007,6 : 2959-2966.
  • 4Mattem J, Koomagi R, Volta M. Biological characterization of subgroups of squamous cell lung carcinomas. Clin Cancer Res, 1999,5 : 1459-1463.
  • 5Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis : a new significant and independent prognostic indicator in early-stage breast carcinoma. J Nalt Cancer Inst, 1992,84: 1875-1887.
  • 6Fingar DC ,Blenis J. Target of rapamycin(TOR) : an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene ,2004,23:3151-3171.
  • 7Abraham RT, Wiederrecht GJ. Immunopharmacology of rapamycin. Annu Rev Immunol, 1996,14 : 483-510.
  • 8Ai W, Bertram PG, Tsang CK, et al. Regulation of subtelomeric silencing during stress response. Mol Cell,2002,10 : 1295-1305.
  • 9Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1995,1 : 27-31.
  • 10Makino Y, CaoR, Svensson K, et al. Inhibitory PAS domain Protein is a negative regulator of hypoxia-inducible gene expression. Nature ,2001,414 (6863) :550-554.

共引文献43

同被引文献26

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部